Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial

S. Lehéricy | M. Chupin | P. Robert | J. Dartigues | M. Weiner | J. Darcourt | M. Zanca | K. Bennys | J. Touchon | M. Allard | C. Dufouil | P. Livet | P. Payoux | P. Legrand | S. Belleville | S. Andrieu | S. Chanalet | Y. Rolland | B. Vellas | N. Coley | S. Guyonnet | I. Carrié | L. Brigitte | C. Faisant | F. Lala | J. Delrieu | H. Villars | Emeline Combrouze | Carole Badufle | A. Zueras | C. Cantet | Christophe Morin | G. A. Kan | C. Dupuy | C. Caillaud | P. Ousset | B. Fougère | S. Willis | B. Gilbert | F. Fontaine | Isabelle Marcet | F. Delva | Sandrine Cerda | Corinne Costes | O. Rouaud | P. Manckoundia | V. Quipourt | S. Marilier | Evelyne Franon | L. Bories | Marie-Laure Pader | Marie-France Basset | Bruno Lapoujade | V. Faure | C. Malick-Loiseau | Evelyne Cazaban-Campistron | F. Desclaux | Colette Blatge | T. Dantoine | C. Laubarie-Mouret | I. Saulnier | J. Clément | M. Picat | L. Bernard-Bourzeix | S. Willebois | I. Desormais | Noëlle Cardinaud | M. Bonnefoy | P. Rebaudet | Claire Gédéon | Catherine Burdet | Flavien Terracol | Stephanie Roth | S. Chaillou | S. Louchart | K. Sudres | N. Lebrun | Nadège Barro-Belaygues | A. Gabelle | Aurélia Romano | Lynda Touati | C. Marelli | Cécile Pays | F. Duff | C. Gervais | S. Gonfrier | Y. Gasnier | S. Bordes | Danièle Begorre | Christian Carpuat | Khaled Khales | Jean-François Lefebvre | Samira Misbah El Idrissi | Pierre Skolil | J. Salles | Ali Bouhayia | F. Ricolfi | D. Dubois | F. Cotton | A. Bonafe | Françoise Hugon | F. Bonneville | C. Cognard | François Chollet | Sophie Peiffer | A. Hitzel | L. Molinier | H. Derumeaux | Christian Vincent | Bertrand Perret | C. Vinel | T. Voisin | J. F. Mangin | Alexandra Foubert | Alain Pesce | Jacques Monteil | J. Caubère | M. Cufi | Marie Noëlle-Cuffi | Michael Li | Yu-Ring Tong | M. Paule | Bonceour Martel | N. Costa | P. Olivier-Abbal | A. Pesce | P. Olivier‐Abbal | L. Bernard‐Bourzeix | N. Cardinaud | A. Romano | B. Perret | Claire Vinel | Valérie Faure | Cécile Laubarie-Mouret | Stéphanie Willebois | Pascale Rebaudet

[1]  F. Askénazy,et al.  Why an On-site Inpatient Pediatric Psychiatric Unit Is Needed to Improve Mental Health Care in the Pediatric Emergency Department of Lenval Hospital, Nice, France. , 2017, Pediatric emergency care.

[2]  F. Askénazy.  Les tribulations d’un pédopsychiatre en recherche clinique , 2017 .

[3]  B. Vellas,et al.  Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial , 2016, Alzheimer's & Dementia.

[4]  L. Schneider,et al.  Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.

[5]  Bruno Vellas,et al.  Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions , 2015, The Lancet Neurology.

[6]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[7]  M. Pontecorvo,et al.  Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Nandini Raghavan,et al.  Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. , 2015, Journal of Alzheimer's disease : JAD.

[9]  R. Sperling,et al.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. , 2014, JAMA neurology.

[10]  M. Weiner,et al.  MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA. , 2014, The journal of prevention of Alzheimer's disease.

[11]  H. Amièva,et al.  Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline. , 2014, Brain : a journal of neurology.

[12]  Jennifer G. Robinson,et al.  Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes , 2014, Neurology.

[13]  C. DeCarli,et al.  Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging , 2012, Neurology.

[14]  Kewei Chen,et al.  Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. , 2011, Archives of neurology.

[15]  S. Studenski,et al.  Gait speed and survival in older adults. , 2011, JAMA.

[16]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[17]  Marcus Richards,et al.  Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. , 2010, The American journal of clinical nutrition.

[18]  M. Inzitari,et al.  Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force , 2009, The journal of nutrition, health & aging.

[19]  B. Fraysse,et al.  Prevention of progression to dementia in the elderly: Rationale and proposal for a health-promoting memory consultation (an IANA task force) , 2008, The journal of nutrition, health & aging.

[20]  A. Beekman,et al.  Effect of fish oil on cognitive performance in older subjects , 2008, Neurology.

[21]  S. Hercberg,et al.  The French National Nutrition and Health Program: 2001–2006–2010 , 2008, International Journal of Public Health.

[22]  F. Hu,et al.  Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. , 2007, The American journal of clinical nutrition.

[23]  K. Markides,et al.  Does 8‐Foot Walk Time Predict Cognitive Decline in Older Mexicans Americans? , 2007, Journal of the American Geriatrics Society.

[24]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[25]  D. Bennett,et al.  ADCS Prevention Instrument Project: Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical Trials , 2006, Alzheimer disease and associated disorders.

[26]  Hilkka Soininen,et al.  Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study , 2006, The Lancet Neurology.

[27]  Jean-François Dartigues,et al.  The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.

[28]  L. Ferrucci,et al.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[29]  B. Heude,et al.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.

[30]  Suzanne G. Leveille,et al.  Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  Y. Joanette,et al.  [Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level]. , 1990, Acta neurologica Belgica.

[32]  Y. Hochberg.  A sharper Bonferroni procedure for multiple tests of significance , 1988 .

[33]  H. Buschke,et al.  Screening for dementia by memory testing , 1988, Neurology.

[34]  Lawton Mp.  Scales to measure competence in everyday activities. , 1988 .

[35]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[36]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[37]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[38]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[39]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .